National Academies Press: OpenBook
« Previous: 9 Moving Forward: Filling the Data Gaps
Suggested Citation:"Appendix A: Workshop Agenda." Institute of Medicine. 2014. Caffeine in Food and Dietary Supplements: Examining Safety: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/18607.
×

A

Workshop Agenda

Caffeine in Food and Dietary Supplements: Examining Safety

Planning Committee on Potential Health Hazards Associated with
Consumption of Caffeine in Food and Dietary Supplements


The National Academies Lecture Room
2101 Constitution Avenue NW
Washington, DC 20418

August 5–6, 2013

WORKSHOP OBJECTIVES

•   Evaluate the epidemiological, toxicological, clinical, and other relevant literature to describe important health hazards associated with caffeine consumption

•   Delineate vulnerable populations who may be at risk from caffeine exposure

•   Describe caffeine exposure and risk of cardiovascular and other health effects on vulnerable populations, including additive effects with other ingredients and effects related to preexisting conditions

•   Explore safe caffeine exposure levels for general and vulnerable populations

•   Identify data gaps on caffeine stimulant effects including but not limited to cardiovascular, central nervous system, or other health outcomes

Suggested Citation:"Appendix A: Workshop Agenda." Institute of Medicine. 2014. Caffeine in Food and Dietary Supplements: Examining Safety: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/18607.
×

August 5, 2013

 

8:00–8:45 a.m.

Registration

INTRODUCTION AND OPENING REMARKS

8:50 a.m.

Welcome

Lynn Goldman, George Washington University, Chair, Planning Committee on Potential Health Hazards Associated with Consumption of Caffeine in Food and Dietary Supplements

9:00 a.m.

Opening Remarks

Margaret Hamburg, Commissioner of Food and Drugs, Food and Drug Administration

SESSION 1: INTAKE AND EXPOSURE TO CAFFEINE

 

Moderated by Barbara Petersen, Exponent

9:15 a.m.

Examining Exposure to Caffeine in Foods, Beverage, and Supplements

Caffeine Intakes from Beverages in the United States

Diane Mitchell, Penn State University

Trends in Caffeine Consumption

Victor Fulgoni III, Nutrition Impact, LLC

10:00 a.m.

Panel Discussion with Speakers

10:30 a.m.

Break

Suggested Citation:"Appendix A: Workshop Agenda." Institute of Medicine. 2014. Caffeine in Food and Dietary Supplements: Examining Safety: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/18607.
×

SESSION 2: SAFETY SIGNALS AND SURVEILLANCE OF POPULATIONS

 

Moderated by Steve Lipshultz, University of Miami

10:50 a.m.

Type and Frequency of Caffeine Toxicity: U.S. and International Surveillance

Alvin Bronstein, Rocky Mountain Poison Center

11:10 a.m.

Safety Assessment of Caffeine in Foods and Beverages

Ashley Roberts, Intertek Cantox Consulting (by WebEx)

11:30 a.m.

Panel Discussion with Speakers

12:00 p.m.

Break for Lunch

SESSION 3: CAFFEINE EFFECTS ON THE CARDIOVASCULAR SYSTEM

 

Moderated by Stephen Daniels, Children’s Hospital, University of Colorado, Denver

1:00 p.m.

Vascular Effects of Caffeine

John Higgins, University of Texas Medical School

1:20 p.m.

Caffeine and Risk of Arrhythmia

Jeffrey Goldberger, Northwestern University

1:40 p.m.

Caffeine and Risk of Hypertension

Ahmed El-Sohemy, University of Toronto (by WebEx)

2:00 p.m.

Panel Discussion with Speakers

Suggested Citation:"Appendix A: Workshop Agenda." Institute of Medicine. 2014. Caffeine in Food and Dietary Supplements: Examining Safety: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/18607.
×

SESSION 4: CAFFEINE EFFECTS ON THE CENTRAL NERVOUS SYSTEM

 

Moderated by Thomas Gould, Temple University

2:20 p.m.

Neuropharmacologic Effects of Caffeine Exposure

Sergi Ferré, National Institutes of Health, National Institute on Drug Abuse

2:40 p.m.

Developmental Neurological Effects of Caffeine Exposure

Jennifer Temple, University of Buffalo (by WebEx)

3:00 p.m.

Panel Discussion with Speakers

3:20 p.m.

Break

SESSION 5: PANEL DISCUSSION: BEHAVIORAL EFFECTS ASSOCIATED WITH CAFFEINE CONSUMPTION

 

Moderated by Richard Adamson, TPN Associates

3:30 p.m.

Dependence/Tolerance

Roland Griffiths, Johns Hopkins University

Addiction

Charles O’Brien, University of Pennsylvania

Risk Taking

Amelia Arria, University of Maryland, College Park

4:30 p.m.

Public Comments

Suggested Citation:"Appendix A: Workshop Agenda." Institute of Medicine. 2014. Caffeine in Food and Dietary Supplements: Examining Safety: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/18607.
×

PUBLIC COMMENTS AND CONCLUDING REMARKS

5:00 p.m.

Concluding Remarks for Day 1

Lynn Goldman, George Washington University, Chair, Planning Committee on Potential Health Hazards Associated with Consumption of Caffeine in Food and Dietary Supplements

5:10 p.m.

Adjourn Meeting

August 6, 2013

 

8:50 a.m.

Welcome and Summary from Day 1

Lynn Goldman, George Washington University, Chair, Planning Committee on Potential Health Hazards Associated with Consumption of Caffeine in Food and Dietary Supplements

9:00 a.m.

Opening Remarks

Michael Taylor, Deputy Commissioner for Foods and Veterinary Medicine, Food and Drug Administration

SESSION 1: OTHER COMPOUNDS IMPACTING CAFFEINE EFFECTS

 

Moderated by James Coughlin, Coughlin & Associates

9:15 a.m.

Facilitated Discussion: Other Components Impacting Caffeine Effects

Led by Stephen Schaffer, University of South Alabama

Summary of the Issues

Stephen Schaffer

Panel Discussion

Speakers from Day 1

Suggested Citation:"Appendix A: Workshop Agenda." Institute of Medicine. 2014. Caffeine in Food and Dietary Supplements: Examining Safety: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/18607.
×

SESSION 2: USE OF CAFFEINATED PRODUCTS

 

Moderated by: James Coughlin, Coughlin & Associates

10:15 a.m.

Trends in Usage and Potential Benefits from Caffeine

Andrew Smith, Cardiff University, UK (by WebEx)

10:35 a.m.

Q&A

SESSION 3: EXPLORING SAFE CAFFEINE EXPOSURE LEVELS

10:45 a.m.

Panel Discussion: Exploring Safe Caffeine Exposure Levels for Vulnerable Populations

Panel Moderator

Mark Feeley, Health Canada

Pregnancy/Infants

Christina Chambers, University of California, San Diego

Children/ Young Adults

Steve Lipshultz, University of Miami

11:30 a.m.

Break for Lunch

SESSION 4: DATA GAPS

 

Moderated by Joe Rodricks, Environ International

12:30 p.m.

Panel Discussion on Data Gaps and Future Research

Stephen Schaffer, University of South Alabama

Christina Chambers, University of California, San Diego

Suggested Citation:"Appendix A: Workshop Agenda." Institute of Medicine. 2014. Caffeine in Food and Dietary Supplements: Examining Safety: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/18607.
×

 

Steve Lipshultz, University of Miami

Regan Bailey, National Institutes of Health, Office of Dietary Supplements

Amelia Arria, University of Maryland, College Park

Alvin Bronstein, Rocky Mountain Poison Center

1:45 p.m.

Chair’s Summary and Final Thoughts

Lynn Goldman, George Washington University, Chair, Planning Committee on Potential Health Hazards Associated with Consumption of Caffeine in Food and Dietary Supplements

2:00 p.m.

Adjourn Meeting

Suggested Citation:"Appendix A: Workshop Agenda." Institute of Medicine. 2014. Caffeine in Food and Dietary Supplements: Examining Safety: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/18607.
×

This page intentionally left blank.

Suggested Citation:"Appendix A: Workshop Agenda." Institute of Medicine. 2014. Caffeine in Food and Dietary Supplements: Examining Safety: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/18607.
×
Page 167
Suggested Citation:"Appendix A: Workshop Agenda." Institute of Medicine. 2014. Caffeine in Food and Dietary Supplements: Examining Safety: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/18607.
×
Page 168
Suggested Citation:"Appendix A: Workshop Agenda." Institute of Medicine. 2014. Caffeine in Food and Dietary Supplements: Examining Safety: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/18607.
×
Page 169
Suggested Citation:"Appendix A: Workshop Agenda." Institute of Medicine. 2014. Caffeine in Food and Dietary Supplements: Examining Safety: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/18607.
×
Page 170
Suggested Citation:"Appendix A: Workshop Agenda." Institute of Medicine. 2014. Caffeine in Food and Dietary Supplements: Examining Safety: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/18607.
×
Page 171
Suggested Citation:"Appendix A: Workshop Agenda." Institute of Medicine. 2014. Caffeine in Food and Dietary Supplements: Examining Safety: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/18607.
×
Page 172
Suggested Citation:"Appendix A: Workshop Agenda." Institute of Medicine. 2014. Caffeine in Food and Dietary Supplements: Examining Safety: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/18607.
×
Page 173
Suggested Citation:"Appendix A: Workshop Agenda." Institute of Medicine. 2014. Caffeine in Food and Dietary Supplements: Examining Safety: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/18607.
×
Page 174
Next: Appendix B: Workshop Attendees »
Caffeine in Food and Dietary Supplements: Examining Safety: Workshop Summary Get This Book
×
Buy Paperback | $54.00 Buy Ebook | $43.99
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

Caffeine in Food and Dietary Supplements is the summary of a workshop convened by the Institute of Medicine in August 2013 to review the available science on safe levels of caffeine consumption in foods, beverages, and dietary supplements and to identify data gaps. Scientists with expertise in food safety, nutrition, pharmacology, psychology, toxicology, and related disciplines; medical professionals with pediatric and adult patient experience in cardiology, neurology, and psychiatry; public health professionals; food industry representatives; regulatory experts; and consumer advocates discussed the safety of caffeine in food and dietary supplements, including, but not limited to, caffeinated beverage products, and identified data gaps.

Caffeine, a central nervous stimulant, is arguably the most frequently ingested pharmacologically active substance in the world. Occurring naturally in more than 60 plants, including coffee beans, tea leaves, cola nuts and cocoa pods, caffeine has been part of innumerable cultures for centuries. But the caffeine-in-food landscape is changing. There are an array of new caffeine-containing energy products, from waffles to sunflower seeds, jelly beans to syrup, even bottled water, entering the marketplace. Years of scientific research have shown that moderate consumption by healthy adults of products containing naturally-occurring caffeine is not associated with adverse health effects. The changing caffeine landscape raises concerns about safety and whether any of these new products might be targeting populations not normally associated with caffeine consumption, namely children and adolescents, and whether caffeine poses a greater health risk to those populations than it does for healthy adults. This report delineates vulnerable populations who may be at risk from caffeine exposure; describes caffeine exposure and risk of cardiovascular and other health effects on vulnerable populations, including additive effects with other ingredients and effects related to pre-existing conditions; explores safe caffeine exposure levels for general and vulnerable populations; and identifies data gaps on caffeine stimulant effects.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!